Medicamentos actuales y emergentes “Existen muchas opciones terapéuticas disponibles, pero sigue siendo un desafío hacer coincidir el medicamento correcto con el paciente correcto” Recuerdo en mi memoria ... es junio de 2016, y acabo [...]
Senior Scientific Director Pete Knox reports on current and emerging GIST treatments and the mutations they address. New research in GIST is happening, and there may be even more therapies around the corner.
New GIST Treatments by Prof. Merimsky
GIST Treatment Updates presented by Dr. Ciara Kelly of Memorial Sloan Kettering Cancer Center at New Horizons 2019 in Wayne, NJ.
On April 6th, 2018, Executive Director, Norman Scherzer; Data Analyst, Jerry Call; Real World Evidence Scientist, Yu Wang, and Patient Registry Director, Denisse Montoya, of The Life Raft Group, were invited to present at [...]
New Horizons – Access to GIST Treatment in Low and Middle Income Countries: The Good, The Bad, and The Ugly
Pat Garcia-Gonzalez presents, "Access to GIST Treatment in Low and Middle Income Countries: The Good, The Bad, and The Ugly" at New Horizons GIST Meeting in Wayne, NJ on Oct. 2, 2017.
The Life Raft Group had the pleasure of hosting the global New Horizons GIST meeting this year in our Wayne, New Jersey office. This international meeting traditionally gathers global GIST advocates with the shared [...]
This is the 16 year commemoration video that highlights the incredible collaboration among patients, caregivers, the medical community, government, and industry to make the initiation of GIST treatment possible. [...]
Two recent articles summarize the promise that immunotherapy provides for the future of cancer treatment. Immunotherapy refers to treatments that aid your own immune system in fighting cancer cells. The first, from U.S. News [...]
In a recent article in the May 2015 edition of the European Journal of Cancer, Heikki Joensuu, one of the foremost authorities on adjuvant treatment for GIST, discussed how follow-up treatment is currently performed for [...]